Category: Pharma News

D. Pharm Exit Exam 2024 – जाने क्या pattern हो सकता है |

डिप्लोमा इन फार्मेसी एग्जिट एग्जामिनेशन (DPEE) का उद्देश्य यह सुनिश्चित करना है कि राज्य फार्मेसी काउंसिल के साथ फार्मासिस्ट के रूप में पंजीकरण के लिए आवेदन करने वाले उम्मीदवार ने फार्मेसी शिक्षा और डिप्लोमा इन फार्मेसी (D.Pharm) पाठ्यक्रम में एक व्यापक व्यावहारिक प्रशिक्षण कार्यक्रम प्राप्त किया है। शिक्षा विनियम, 2020 या विनियम जो फार्मेसी अधिनियम, 1948 की धारा 12 के तहत फार्मेसी काउंसिल ऑफ इंडिया द्वारा अनुमोदित संस्थान में समय-समय पर लागू हो सकते हैं और दवाओं के वितरण और फार्मेसी अभ्यास के अन्य क्षेत्रों में मुख्य दक्षता हासिल कर सकते हैं।

DCGI Sets Common Cold Medication Warnings for Children Under Four Years

A significant directive impacting the production and marketing of common cold fixed dosage combinations (FDC) including chlorpheniramine maleate IP 2 mg and phenylephrine HCL IP 5 mg per millilitre drops has been issued by the Drugs Controller General of India (DCGI) in a recent development. Prompted by suggestions from a Subject Expert Committee (SEC) focused on pulmonary issues, the directive requires manufacturers to advise against using this combination in children younger than four years old on the label, package insert, and promotional materials.

Mandatory Exit Test for D. Pharma Students – Dr. Montu M Patel

Exciting developments are underway in the pharmaceutical education sector, as plans for a new pharmacy college are set in motion. According to Dr. Montu M Patel, Chairman of the Pharmacy Council of India, it will take approximately a year to establish this groundbreaking institution. The initiative aims not only to meet diverse educational needs but also to address practical requirements within the system.

Urgent Alert: Safety Concerns Surrounding Meftal Spas – The Dangers of Mefenamic Acid Revealed

If you rely on Meftal Spas to alleviate pain, menstrual cramps, or manage rheumatoid arthritis, this news is of paramount importance. The Indian Pharmacopoeia Commission (IPC) has issued a critical drug safety alert, sounding the alarm on Meftal’s active ingredient, mefenamic acid. The alert underscores potential adverse reactions that could lead to a severe condition known as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome.

Back to top
WhatsApp Join Telegram